The Australian-developed Minder system is an implantable device for continuous monitoring of brain activity in patients with epilepsy, developed to address the shortcomings in current ...

First clinical trial published demonstrating safety and efficacy of a bilateral continuous EEG monitoring system Clinically relevant findings were identified in 88% of patients High-quality, durable ...

The U.S. FDA has granted de novo clearance for Epiminder Pty. Ltd.’s Minder implantable device for continuously monitoring brain activity in patients with epilepsy.

Please provide your email address to receive an email when new articles are posted on . The portable in-ear EEG aims to integrate real-time brain activity data into daily life. Medical consultation is ...

Researchers from Massachusetts General Hospital in Boston identified an electroencephalogram brain pattern that signals the loss and regaining of consciousness for patients under propofol anesthesia, ...

First clinical trial published demonstrating safety and efficacy of a bilateral continuous EEG monitoring system Clinically relevant findings were identified in 88% of patients High-quality, durable ...